“A Sensitive Bioanalytical Method Development And Validation Of Pazopanib In Human Plasma By LC-ESI-MS/MS”, Journal of Pharmaceutical Negative Results, pp. 855–861, Nov. 2022, doi: 10.47750/pnr.2022.13.S09.102.